SNNA

Sienna Biopharmaceuticals, Inc.

SNNA

Delisted

SNNA was delisted on the 16th of December, 2019.

23 hedge funds and large institutions have $1.08M invested in Sienna Biopharmaceuticals, Inc. in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 13 reducing their positions, and 25 closing their positions.

New

Increased

Maintained

Reduced

Closed

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders

Holders Change

Holders Change %

% of All Funds

Holding in Top 10

–

Holding in Top 10 Change

Holding in Top 10 Change %

% of All Funds

New

Increased

Reduced

Closed

Calls

–

Puts

–

Net Calls

Net Calls Change

Top Buyers

1		+$8.78K
2		+$1.28K
3		+$56

Top Sellers

1		-$2.25M
2		-$1.62M
3		-$660K
4	Renaissance Technologies New York	-$510K
5	WCM Wildcat Capital Management New York	-$257K

#	Name	Holding
26	26	–
27	27	–
28	28	–
29	29	–
30	30	–
31	31	–
32	32	–
33	33	–
34	34	–
35	35	–
36	36	–
37	37	–
38	38	–
39	39	–
40	40	–
41	41	–
42	42	–

#	Name	Holding
26	26	–
27	27	–
28	28	–
29	29	–
30	30	–
31	31	–
32	32	–
33	33	–
34	34	–
35	35	–
36	36	–
37	37	–
38	38	–
39	39	–
40	40	–
41	41	–
42	42	–

#	Name	Holding
26	26	–
27	27	–
28	28	–
29	29	–
30	30	–
31	31	–
32	32	–
33	33	–
34	34	–
35	35	–
36	36	–
37	37	–
38	38	–
39	39	–
40	40	–
41	41	–
42	42	–

Sienna Biopharmaceuticals, Inc. SNNA